Sleep and allergic rhinitis

Journal of Investigational Allergology and Clinical Immunology

Volumn 18, Issue 6, 2008, Pages 415-419

  Mullol, Joaquim ^a,b,c,d   Maurer, M ^d,e   Bousquet, J ^d,f,g  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d GA2LEN (Global Allergy and Asthma European Network)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIV MONTPELLIER   (France)

^g INSERM   (France)

Author keywords

Allergic rhinitis; Antihistamines; ARIA; Nasal corticosteroids; Quality of life; Sleep

Indexed keywords

DESLORATADINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE; MONTELUKAST; PSEUDOEPHEDRINE;

ALLERGIC RHINITIS; CLINICAL TRIAL; EMOTIONAL DISORDER; HUMAN; INSOMNIA; MENTAL HEALTH; NOSE CONGESTION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; SOCIAL INTERACTION;

ANTI-ALLERGIC AGENTS; CHRONIC DISEASE; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SLEEP; SLEEP APNEA SYNDROMES; SLEEP DISORDERS;

EID: 57349177915     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Baiardini I, Braido F, Cauglia S, Canonica GW. Sleep disturbances in allergic diseases. Allergy. 2006;61:1259-67.
2. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62(Suppl 85):17-25.
3. Magnan A, Meunier JP, Saugnac C, Gasteau J, Neukirch F. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy. 2007;63:292-8.
4. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy. 2007;62(Suppl 85):9-16.
5. Bieber T, Vick K, Folster-Holst R, Belloni-Fortina A, Stadtler G, Worm M, Arcangeli F. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy. 2007;62:184-9.
6. Humbert M, Holgate S, Boulet LP, Bousquet J. Asthma control or severity: that is the question. Allergy. 2007;62:95-101.
7. Chen W, Kushida CA. Nasal obstruction in sleep-disordered breathing. Otolaryngol Clin North Am. 2003;36:437-60.
8. Wohrl S, Vigl K, Binder M, Stingl G, Prinz M. Automated measurement of skin prick tests: an advance towards exact calculation of wheal size. Exp Dermatol. 2006;15:119-24.
9. Falcone FH, Zillikens D, Gibbs BF. The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity. Exp Dermatol. 2006;15:855-64.
10. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol. 1994;94:182-8.
11. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104:364-9.
12. Pratt EL, Craig TJ. Assessing outcomes from the sleep disturbance associated with rhinitis. Curr Opin Allergy Clin Immunol. 2007;7:249-56.
13. van Oene CM, van Reij EJ, Sprangers MA, Fokkens WJ. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy. 2007;62:1359-71.
14. Juniper EF, Riis B, Juniper BA. Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire Allergy. 2007;62:1091-3.
15. Valero A, Alonso J, Antépara I, Baró E, Colás C, del Cuvillo A, Ferrer M, Herdman M, Marti-Guadaño E, Monclús L, Navarro-Pulido AM, Sastre J, Izquierdo I, Mullol J. Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires. Allergy. 2007;62:1372-8.
16. ESPRINT Study Group: Valero A, J Alonso, I Antépara, E Baró, C Colás, A del Cuvillo, M Ferrer, M Herdman, E Martí-Guadaño, L Monclús, J Mullol, AM Navarro-Pulido, C Navas, J Sastre. Development and validation of a new spanish instrument to measure Health-Related Quality of Life in patients with allergic rhinitis: the ESPRINT questionnaire. Value Health. 2007;10:466-77.
17. Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2003;111:484-90.
18. Juniper EF, Stahl E, Doty RL, Simons FE, Allen DB, Howarth PH. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol. 2005;115:S390-413.
19. Stuck BA, Czajkowski J, Hagner AE, Klimek L, Verse T, Hormann K, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol. 2004;113:663-8.
20. Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Méchim H, Daures JP, Bousquet J. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62:367-72.
21. Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, Allaf B. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006;117:158-62.
22. Léger D, Annesi-Maesano I, Carat F, Rugina M, Chanal I, Pribil C, El Hasnaoui A, Bousquet J. Allergic rhinitis and its consequences on quality of sleep: an unexplored area. Arch Intern Med. 2006;166:1744-8.
23. Olsen KD, Kern EB, Westbrook PR. Sleep and breathing disturbance secondary to nasal obstruction. Otolaryngol Head Neck Surg. 1981;89:804-10.
24. Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol. 1998;101:633-7.
25. Meltzer EO. Introduction: Stuffy is also related to Sleepy and Grumpy - the link between rhinitis and sleep-disordered breathing. J Allergy Clin Immunol. 2004;114(5 Suppl):S133-4.
26. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol. 1997;99:S757-62.
27. Kaditis AG, Finder J, Alexopoulos EL, Starantzis K, Tanou K, Gampeta S, Agorogiannis E, Christodoulou S, Pantazidou A, Gourgoulianis K, Molyvdas PA. Sleep-disordered breathing in 3,680 Greek children. Pediatr Pulmonol. 2004;37:499-509.
28. Ng DK, Chan CH, Kwok KL, Cheung JM. Allergic rhinitis as a risk factor for habitual snoring in children. Chest. 2005;127:2285-2286.
29. Marshall NS, Almqvist C, Grunstein RR, Marks GB. Predictors for snoring in children with rhinitis at Age 5. Pediatr Pulmonol. 2007;42:584-91.
30. Hellgren J, Omenaas E, Gíslason T, Jögi R, Franklin KA, Lindberg E, Janson C, Torén K, RHINE Study Group, North Europe. Perennial non-infectious rhinitis-an independent risk factor for sleep disturbances in Asthma. Respir Med. 2007;101:1015-20.
31. Qidwai JC, Watson GS, Weiler JM. Sedation, cognition, and antihistamines. Curr Allergy Asthma Rep. 2002;2:216-22.
32. Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe MP, Sullivan CL, Day JH. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91:375-85.
33. Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Fujii T, Komemushi S, Itoh M, Sasaki H, Watanabe T, Yanai K. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration. Br J Clin Pharmacol. 2002;53:296-304.
34. Mohler SR, Nicholson A, Harvey P, Miura Y, Meeves SG. The use of antihistamines in safety-critical jobs: a meeting report. Curr Med Res Opin. 2002;18:332-7.
35. Santos CB, Pratt EL, Hanks C, McCann J, Craig TJ. Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immunol 2006; 97: 579-86.
36. Nicholson AN, Handford AD, Turner C, Stone BM. Studies on performance and sleepiness with the H1-antihistamine, desloratadine. Aviat Space Environ Med. 2003;74:809-15.
37. Mansfield L, Mendoza C, Flores J, Meeves SG. Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA). Ann Allergy Asthma Immunol. 2003;90:554-9.
38. Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91:354-61.
39. Bronsky E, Boggs P, Findlay S, Gawchik S, Georgitis J, Mansmann H, Sholler L, Wolfe J, Meltzer E, Morris R. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol. 1995;96:139-47.
40. Bertrand B, Jamart J, Marchal JL, Arendt C. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study. Rhinology. 1996;34:91-6.
41. Kaiser HB, Banov CH, Banov CH, Berkowitz RR, Bernstein DI, Bronsky EA, Georgitis JW, Mendelson LM, Rooklin AR, Sholler LJ, Striker WW, Harrison JE, Danzig MR, Lorber RR. Comparative Efficacy and Safety of Once-Daily Versus Twice-Daily Loratadine-Pseudoephedrine Combinations Versus Placebo in Seasonal Allergic Rhinitis. Am J Ther. 1998;5:245-51.
42. Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92:73-9.
43. Mansfield LE, Diaz G, Posey CR, Flores-Neder J. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol. 2004;92:240-44.
44. Hughes K, Glass C, Ripchinski M, Gurevich F, Weaver TE, Lehman E, Fisher LH, Craig TJ. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy. 2003;58:380-85.
45. Gurevich F, Glass C, Davies M, Wei W, McCann J, Fisher L, Chegini S, Mende C, Craig T. The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2005;26:268-74.
46. Mansfield LE, Posey CR. Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate. Allergy Asthma Proc. 2007;28:226-9.
47. Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol. 2004;92:255-61.
48. Craig TJ, Mende C, Hughes K, Kakumanu S, Lehman EB, Chinchilli V. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc. 2003;24:53-8.
49. Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007;62:1078-84.
50. Craig TJ, Hanks CD, Fisher LH. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis? J Allergy Clin Immunol. 2005;116:1264-66.
51. Kakumanu S, Glass C, Craig T. Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. Am J Respir Med. 2002;1:195-200.
52. Bousquet J, Duchateau J, Pignat JC, Fayol C, Marquis P, Mariz S, Ware JE, Valentin B, Burtin B. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol. 1996;98:309-16.
53. Pradalier A, Neukirch C, Dreyfus I, Devillier P. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Allergy. 2007;62:1331-4.
54. Bachert C, J Bousquet, GW Canonica, SR Durham, L Klimek, J Mullol, PB Van Cauwenberge, G Van Hammée and the XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004;114:838-44.
55. Meltzer EO, Philip G, Weinstein SF, LaForce CF, Malice MP, Dass SB, Santanello NC, Reiss TF. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Am J Rhinol. 2005;19:591-8.
56. Ng DK, Chan CH, Hwang GY, Chow PY, Kwok KL. A review of the roles of allergic rhinitis in childhood obstructive sleep apnea syndrome. Allergy Asthma Proc. 2006;27:240-2.
57. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with coexisting rhinitis. Thorax. 2004;59:50-5.
58. Almendros I, Acerbi I, Vilaseca I, Montserrat JM, Navajas D, Farré R. Continuous positive airway pressure (CPAP) induces early nasal inflammation. Sleep. 2008;31:127-31.
59. Morris LG, Setlur J, Burschtin OE, Steward DL, Jacobs JB, Lee KC. Acoustic rhinometry predicts tolerance of nasal continuous positive airway pressure: a pilot study. Am J Rhinol. 2006;20:133-7.
60. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest. 1999;116:403-8.
61. Winck JC, Delgado JL, Almeida JM, Marques JA. Heated humidification during nasal continuous positive airway pressure for obstructive sleep apnea syndrome: objective evaluation of efficacy with nasal peak inspiratory flow measurements. Am J Rhinol. 2002;16:175-7.